ICCM - Why Is Medical Device Firm IceCure Medical Stock Trading Lower Today? | Benzinga
The FDA has denied IceCure Medical Ltd's (NASDAQ: ICCM) De Novo Classification request for the ProSense System for breast cancer, which was submitted based on interim analysis from its ICE3 study.
ProSense cryoablation (a procedure that uses cold to treat cancer) is a minimally invasive, non-surgical, outpatient 40-minute procedure requiring only a local 1% lidocaine injection.
The FDA's position on the ...